GLUT1 expression has been shown to be correlated with tumor FDG uptake in salivary gland pleomorphic adenomas [44], esophageal squamous cell carcinoma [45], and high-risk prostate cancer [46]. The gene discussed is SLC2A1; the disease is neoplasm.